Autonomix Medical Common Key Fundamental Indicators
| AMIX Stock | 0.36 0.03 8.13% |
As of the 12th of February 2026, Autonomix Medical shows the Standard Deviation of 9.4, mean deviation of 5.38, and Risk Adjusted Performance of (0.06). Autonomix Medical Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Autonomix Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Autonomix Medical's valuation are provided below:We have found ninety-six available fundamental signals for Autonomix Medical Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Autonomix Medical Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
At this time, Autonomix Medical's Research Development is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 168.2 K in 2026, whereas Depreciation And Amortization is likely to drop slightly above 156.5 K in 2026. Autonomix | Select Account or Indicator | Build AI portfolio with Autonomix Stock |
Autonomix Medical Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Autonomix Medical Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Autonomix Medical Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Autonomix Fundamental Market Drivers
Autonomix Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Autonomix Medical is extremely important. It helps to project a fair market value of Autonomix Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Autonomix Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Autonomix Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Autonomix Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autonomix Medical. If investors know Autonomix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Autonomix Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Autonomix Medical Common's market price often diverges from its book value, the accounting figure shown on Autonomix's balance sheet. Smart investors calculate Autonomix Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Autonomix Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Autonomix Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Autonomix Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Autonomix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Autonomix Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Autonomix Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Autonomix Medical.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Autonomix Medical on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Autonomix Medical Common or generate 0.0% return on investment in Autonomix Medical over 90 days. Autonomix Medical is related to or competes with Movano, Kala Pharmaceuticals, Venus Concept, Oragenics, Heart Test, Bone Biologics, and AIM ImmunoTech. Autonomix Medical is entity of United States More
Autonomix Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Autonomix Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Autonomix Medical Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 74.93 | |||
| Value At Risk | (11.93) | |||
| Potential Upside | 9.89 |
Autonomix Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Autonomix Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Autonomix Medical's standard deviation. In reality, there are many statistical measures that can use Autonomix Medical historical prices to predict the future Autonomix Medical's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.90) | |||
| Total Risk Alpha | (1.94) | |||
| Treynor Ratio | (1.17) |
Autonomix Medical February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (1.16) | |||
| Mean Deviation | 5.38 | |||
| Coefficient Of Variation | (1,145) | |||
| Standard Deviation | 9.4 | |||
| Variance | 88.29 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.90) | |||
| Total Risk Alpha | (1.94) | |||
| Treynor Ratio | (1.17) | |||
| Maximum Drawdown | 74.93 | |||
| Value At Risk | (11.93) | |||
| Potential Upside | 9.89 | |||
| Skewness | 3.68 | |||
| Kurtosis | 22.57 |
Autonomix Medical Common Backtested Returns
Autonomix Medical Common secures Sharpe Ratio (or Efficiency) of -0.0813, which signifies that the company had a -0.0813 % return per unit of risk over the last 3 months. Autonomix Medical Common exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Autonomix Medical's Risk Adjusted Performance of (0.06), standard deviation of 9.4, and Mean Deviation of 5.38 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.71, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Autonomix Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Autonomix Medical is expected to be smaller as well. At this point, Autonomix Medical Common has a negative expected return of -0.78%. Please make sure to confirm Autonomix Medical's jensen alpha and rate of daily change , to decide if Autonomix Medical Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.85 |
Very good predictability
Autonomix Medical Common has very good predictability. Overlapping area represents the amount of predictability between Autonomix Medical time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Autonomix Medical Common price movement. The serial correlation of 0.85 indicates that around 85.0% of current Autonomix Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.85 | |
| Spearman Rank Test | 0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 6.71299999999999% of Autonomix Medical Common are shares owned by insiders. This is 55.78% lower than that of the Health Care Equipment & Supplies sector and 56.83% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 33.47% higher than that of the company.
Autonomix Medical Common Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Autonomix Medical's current stock value. Our valuation model uses many indicators to compare Autonomix Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Autonomix Medical competition to find correlations between indicators driving Autonomix Medical's intrinsic value. More Info.Autonomix Medical Common is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Autonomix Medical's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Autonomix Medical's earnings, one of the primary drivers of an investment's value.Autonomix Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Autonomix Medical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Autonomix Medical could also be used in its relative valuation, which is a method of valuing Autonomix Medical by comparing valuation metrics of similar companies.Autonomix Medical is currently under evaluation in shares owned by insiders category among its peers.
Autonomix Fundamentals
| Return On Equity | -3.52 | ||||
| Return On Asset | -1.59 | ||||
| Current Valuation | (7.86 M) | ||||
| Shares Outstanding | 6.91 M | ||||
| Shares Owned By Insiders | 6.71 % | ||||
| Shares Owned By Institutions | 4.96 % | ||||
| Number Of Shares Shorted | 579.65 K | ||||
| Price To Book | 0.44 X | ||||
| EBITDA | (11.05 M) | ||||
| Net Income | (11.41 M) | ||||
| Total Debt | 1.71 M | ||||
| Book Value Per Share | 1.04 X | ||||
| Cash Flow From Operations | (8.26 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | (4.51) X | ||||
| Target Price | 6.6 | ||||
| Beta | -2.56 | ||||
| Market Capitalization | 2.87 M | ||||
| Total Asset | 9.81 M | ||||
| Retained Earnings | (50.38 M) | ||||
| Working Capital | 7.9 M | ||||
| Net Asset | 9.81 M |
About Autonomix Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Autonomix Medical Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 210.4 K | 145.2 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.